Shintaro (Shin) Hasegawa is appointed as the President and Chief Executive Officer effective as of November 1, 2019 for the next stage of corporate development. Shin has over twenty years of extensive experiences in pharmaceutical business in various positions, such as research planning, research alliances, regulatory affairs, clinical research planning and business development/licensing with increased responsibility. More recently, he served as the Director and Head, Business Development of BioWa since March 2013 and had led numbers of new licensing deals and alliance managements.

Shin also serves as the Head of Business Development, North America for BioWa's parent company, Kyowa Kirin since November 2019 for a global business development/licensing deal for Kyowa Kirin.

Shin received his Bachelor's degree in Psychology from University of Tokyo.